April 9, 2015
Hisamitsu Pharmaceutical reported on April 8 that its group sales grew 4.1% year on year to 156,743 million yen in the year ended in February as revenues at US subsidiary Noven Pharmaceuticals contributed to countering sluggish ethical drug sales in...read more